Virtu KCG Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$2.24M Buy
24,643
+9,149
+59% +$831K 0.06% 201
2017
Q1
$1.36M Buy
15,494
+1,329
+9% +$117K 0.04% 475
2016
Q4
$1.17M Sell
14,165
-25,474
-64% -$2.11M 0.03% 613
2016
Q3
$3.67M Buy
39,639
+2,166
+6% +$200K 0.09% 121
2016
Q2
$2.92M Buy
37,473
+8,148
+28% +$634K 0.06% 172
2016
Q1
$2.42M Buy
29,325
+17,837
+155% +$1.47M 0.07% 207
2015
Q4
$1.2M Sell
11,488
-3,970
-26% -$416K 0.02% 473
2015
Q3
$1.63M Buy
15,458
+1,569
+11% +$165K 0.03% 361
2015
Q2
$1.9M Buy
13,889
+3,837
+38% +$525K 0.03% 303
2015
Q1
$1.25M Buy
10,052
+3,352
+50% +$418K 0.03% 443
2014
Q4
$606K Buy
+6,700
New +$606K 0.01% 927
2014
Q3
Sell
-3,675
Closed -$229K 2669
2014
Q2
$229K Sell
3,675
-9,673
-72% -$603K ﹤0.01% 1972
2014
Q1
$910K Buy
13,348
+4,779
+56% +$326K 0.01% 616
2013
Q4
$602K Sell
8,569
-3,687
-30% -$259K 0.01% 874
2013
Q3
$885K Buy
+12,256
New +$885K 0.01% 753